• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workers.医护人员对 COVID-19 疫苗的体液免疫反应存在种族和人口统计学差异。
J Med Virol. 2023 Sep;95(9):e29067. doi: 10.1002/jmv.29067.
2
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.在 SARS-CoV-2 初免和既往感染人群中,BNT162b2 mRNA 疫苗对细胞和体液免疫应答的动力学和持久性:加强针和突破性感染的影响。
Front Immunol. 2022 May 31;13:863554. doi: 10.3389/fimmu.2022.863554. eCollection 2022.
3
A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers.一项针对完全接种疫苗的医护人员的 SARS-CoV-2 刺突蛋白受体结合域(RBD)IgG 水平和中和抗体的队列分析。
Clin Chem Lab Med. 2022 Apr 27;60(7):1110-1115. doi: 10.1515/cclm-2022-0322. Print 2022 Jun 27.
4
Durability of COVID-19 humoral immunity post infection and different SARS-COV-2 vaccines.感染后 COVID-19 体液免疫的持久性和不同的 SARS-COV-2 疫苗。
J Infect Public Health. 2024 Apr;17(4):704-711. doi: 10.1016/j.jiph.2024.02.016. Epub 2024 Mar 1.
5
Longitudinal Follow-Up of the Immunity to SARS-CoV-2 in Health Care Workers in Argentina: Persistence of Humoral Response and Neutralizing Capacity after Sputnik V Vaccination.阿根廷卫生保健工作者对 SARS-CoV-2 免疫力的纵向随访:接种卫星 V 疫苗后体液反应和中和能力的持久性。
mSphere. 2023 Jun 22;8(3):e0066222. doi: 10.1128/msphere.00662-22. Epub 2023 Apr 18.
6
Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.韩国医护人员接种第二剂 BNT162b2 mRNA 疫苗 6 个月后仍保持对 SARS-CoV-2 的抗体应答。
Front Immunol. 2022 Jan 31;13:827306. doi: 10.3389/fimmu.2022.827306. eCollection 2022.
7
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial.在接种一剂灭活全病毒 COVID-19 疫苗(VLA2001)加强针后针对原始株、Delta 株和奥密克戎株变异病毒的安全性和免疫原性:COV-COMPARE 随机对照 3 期试验开放标签扩展的中期分析。
J Infect. 2023 Sep;87(3):242-254. doi: 10.1016/j.jinf.2023.06.022. Epub 2023 Jul 3.
8
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.BNT162b2 新冠病毒疫苗与体液免疫应答及动力学的相关性:医护人员前瞻性、单中心、纵向队列研究。
Lancet Respir Med. 2021 Sep;9(9):999-1009. doi: 10.1016/S2213-2600(21)00220-4. Epub 2021 Jul 2.
9
Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination.新冠病毒加强疫苗接种后医护人员队列的后续严重急性呼吸综合征冠状病毒2血清学研究
BMC Infect Dis. 2024 Apr 24;24(1):436. doi: 10.1186/s12879-024-09338-5.
10
Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays.化学发光免疫分析检测疫苗接种和康复 COVID-19 队列中中和抗体和结合抗体的纵向分布。
Immun Inflamm Dis. 2022 Jun;10(6):e612. doi: 10.1002/iid3.612.

引用本文的文献

1
COVID-19 symptom severity and duration among outpatients, July 2021-May 2023: The PROTECT observational study.2021年7月至2023年5月门诊患者中新冠病毒病的症状严重程度和持续时间:PROTECT观察性研究
PLoS One. 2025 Feb 21;20(2):e0314518. doi: 10.1371/journal.pone.0314518. eCollection 2025.
2
Factors associated with elevated SARS-CoV-2 immune response in children and adolescents.儿童和青少年中与新冠病毒免疫反应增强相关的因素。
Front Pediatr. 2024 Aug 15;12:1393321. doi: 10.3389/fped.2024.1393321. eCollection 2024.
3
Estimate the number of lives saved by a SARS-CoV-2 vaccination campaign in six states in the United States with a simple model.用一个简单的模型估算美国六个州开展的新冠病毒疫苗接种活动挽救的生命数量。
IJID Reg. 2024 Jun 15;12:100390. doi: 10.1016/j.ijregi.2024.100390. eCollection 2024 Sep.
4
Duration of Postvaccination Neutralizing Antibodies to SARS-CoV-2 and Medication Effects: Results from the Safety and Immunogenicity of COVID-19 Vaccination in Systemic Immune-Mediated Inflammatory Diseases Cohort Study.接种疫苗后针对新冠病毒的中和抗体持续时间及药物影响:来自系统性免疫介导炎症性疾病队列研究中新冠疫苗安全性和免疫原性的结果
ACR Open Rheumatol. 2024 Sep;6(9):581-586. doi: 10.1002/acr2.11697. Epub 2024 Jul 1.

本文引用的文献

1
Prepandemic cross-reactive humoral immunity to SARS-CoV-2 in Africa: Systematic review and meta-analysis.大流行前非洲人群对 SARS-CoV-2 的交叉反应性体液免疫:系统评价和荟萃分析。
Int J Infect Dis. 2023 Sep;134:160-167. doi: 10.1016/j.ijid.2023.06.009. Epub 2023 Jun 15.
2
Unravelling Antigenic Cross-Reactions toward the World of Coronaviruses: Extent of the Stability of Shared Epitopes and SARS-CoV-2 Anti-Spike Cross-Neutralizing Antibodies.解析针对冠状病毒世界的抗原交叉反应:共享表位的稳定性程度及SARS-CoV-2抗刺突交叉中和抗体
Pathogens. 2023 May 13;12(5):713. doi: 10.3390/pathogens12050713.
3
Immunology of SARS-CoV-2 infection and vaccination.SARS-CoV-2 感染和疫苗接种的免疫学。
Clin Chim Acta. 2023 May 1;545:117390. doi: 10.1016/j.cca.2023.117390. Epub 2023 May 13.
4
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.先前感染 SARS-CoV-2 和混合免疫对奥密克戎变异株和重症疾病的保护效力:系统评价和荟萃回归分析。
Lancet Infect Dis. 2023 May;23(5):556-567. doi: 10.1016/S1473-3099(22)00801-5. Epub 2023 Jan 18.
5
SARS-CoV-2 Antibody Prevalence among Industrial Livestock Operation Workers and Nearby Community Residents, North Carolina, 2021 to 2022.2021 年至 2022 年期间,北卡罗来纳州工业畜牧业工人和附近社区居民中 SARS-CoV-2 抗体流行率。
mSphere. 2023 Feb 21;8(1):e0052222. doi: 10.1128/msphere.00522-22. Epub 2023 Jan 19.
6
Demographic, behavioural and occupational risk factors associated with SARS-CoV-2 infection in UK healthcare workers: a retrospective observational study.与英国医护人员 SARS-CoV-2 感染相关的人口统计学、行为和职业风险因素:一项回顾性观察研究。
BMJ Open. 2022 Nov 7;12(11):e063159. doi: 10.1136/bmjopen-2022-063159.
7
Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Central and West African Populations.大流行前中非人群对 SARS-CoV-2 的交叉反应性免疫。
Viruses. 2022 Oct 14;14(10):2259. doi: 10.3390/v14102259.
8
Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK).新型冠状病毒2疫苗抗体反应的决定因素:基于人群的纵向研究(英国COVIDENCE)
Vaccines (Basel). 2022 Sep 23;10(10):1601. doi: 10.3390/vaccines10101601.
9
Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals.慢性疾病患者与健康的 COVID-19 初筛阴性个体针对 SARS-CoV-2 刺突蛋白的交叉反应性抗体应答存在差异。
Sci Rep. 2022 Oct 7;12(1):16817. doi: 10.1038/s41598-022-20849-6.
10
A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital.一项针对英国一家大型教学医院医护人员 SARS-CoV-2 抗体血清阳性率相关危险因素的前瞻性研究。
J Infect. 2022 Nov;85(5):557-564. doi: 10.1016/j.jinf.2022.08.030. Epub 2022 Sep 2.

医护人员对 COVID-19 疫苗的体液免疫反应存在种族和人口统计学差异。

Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workers.

机构信息

Department of Pathology, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.

Greenwood Genetic Centre, Greenwood, South Carolina, USA.

出版信息

J Med Virol. 2023 Sep;95(9):e29067. doi: 10.1002/jmv.29067.

DOI:10.1002/jmv.29067
PMID:37675796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10536788/
Abstract

The COVID-19 pandemic had a profound impact on global health, but rapid vaccine administration resulted in a significant decline in morbidity and mortality rates worldwide. In this study, we sought to explore the temporal changes in the humoral immune response against SARS-CoV-2 healthcare workers (HCWs) in Augusta, GA, USA, and investigate any potential associations with ethno-demographic features. Specifically, we aimed to compare the naturally infected individuals with naïve individuals to understand the immune response dynamics after SARS-CoV-2 vaccination. A total of 290 HCWs were included and assessed prospectively in this study. COVID status was determined using a saliva-based COVID assay. Neutralizing antibody (NAb) levels were quantified using a chemiluminescent immunoassay system, and IgG levels were measured using an enzyme-linked immunosorbent assay method. We examined the changes in antibody levels among participants using different statistical tests including logistic regression and multiple correspondence analysis. Our findings revealed a significant decline in NAb and IgG levels at 8-12 months postvaccination. Furthermore, a multivariable analysis indicated that this decline was more pronounced in White HCWs (odds ratio [OR] = 2.1, 95% confidence interval [CI] = 1.07-4.08, p = 0.02) and IgG (OR = 2.07, 95% CI = 1.04-4.11, p = 0.03) among the whole cohort. Booster doses significantly increased IgG and NAb levels, while a decline in antibody levels was observed in participants without booster doses at 12 months postvaccination. Our results highlight the importance of understanding the dynamics of immune response and the potential influence of demographic factors on waning immunity to SARS-CoV-2. In addition, our findings emphasize the value of booster doses to ensure durable immunity.

摘要

新型冠状病毒肺炎疫情对全球健康造成了深远影响,但疫苗的快速接种导致全球发病率和死亡率显著下降。本研究旨在探讨美国佐治亚州奥古斯塔的卫生保健工作者(HCWs)对 SARS-CoV-2 的体液免疫反应随时间的变化,并研究其与种族-人口统计学特征的潜在关联。具体而言,我们旨在将自然感染个体与无感染个体进行比较,以了解 SARS-CoV-2 接种后的免疫反应动态。本研究共纳入 290 名 HCWs 进行前瞻性评估。使用基于唾液的 COVID 检测来确定 COVID 状态。使用化学发光免疫分析系统定量测定中和抗体(NAb)水平,并使用酶联免疫吸附试验(ELISA)方法测量 IgG 水平。我们使用逻辑回归和多元对应分析等不同统计检验来检查参与者的抗体水平变化。研究结果显示,接种疫苗后 8-12 个月,NAb 和 IgG 水平显著下降。此外,多变量分析表明,这种下降在白人 HCWs 中更为明显(比值比 [OR] = 2.1,95%置信区间 [CI] = 1.07-4.08,p = 0.02)和整个队列中的 IgG(OR = 2.07,95% CI = 1.04-4.11,p = 0.03)。加强剂量显著增加了 IgG 和 NAb 水平,而在接种疫苗 12 个月后未接种加强剂量的参与者中,抗体水平下降。研究结果强调了了解免疫反应动态以及人口统计学因素对 SARS-CoV-2 衰减免疫的潜在影响的重要性。此外,研究结果强调了加强剂量以确保持久免疫力的重要性。